HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

Christian Reinhard Mayr; Tobias Kiesslich; S Erber; Dino Bekric; Heidemarie Dobias; Markus Ritter; Tarkan Jäger; Neumayer; Eckhard Klieser; Daniel Neureiter

HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

Research output: Contribution to conference › Poster

Original language	Undefined/Unknown
Publication status	Published - 2021
Event	Cholangiocarcinoma Foundation (CCF) Annual Conference 2021 - Herriman, Utah (virtuell), United States Duration: 31 Mar 2021 → 2 Apr 2021

Conference with scientific content

Conference with scientific content	Cholangiocarcinoma Foundation (CCF) Annual Conference 2021
Country/Territory	United States
City	Herriman, Utah (virtuell)
Period	31/03/21 → 2/04/21

1 Abstract

HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.
Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E. & Neureiter, D., 2021.
Research output: Contribution to conference › Abstract

Cite this

@conference{eef7c6ddcfb044348491b70429d61364,

title = "HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.",

author = "Mayr, \{Christian Reinhard\} and Tobias Kiesslich and S Erber and Dino Bekric and Heidemarie Dobias and Markus Ritter and Tarkan J{\"a}ger and Neumayer and Eckhard Klieser and Daniel Neureiter",

year = "2021",

language = "Undefined/Unknown",

note = "Cholangiocarcinoma Foundation (CCF) Annual Conference 2021 ; Conference date: 31-03-2021 Through 02-04-2021",

}

TY - CONF

T1 - HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.

AU - Mayr, Christian Reinhard

AU - Kiesslich, Tobias

AU - Erber, S

AU - Bekric, Dino

AU - Dobias, Heidemarie

AU - Ritter, Markus

AU - Jäger, Tarkan

AU - Neumayer, null

AU - Klieser, Eckhard

AU - Neureiter, Daniel

PY - 2021

Y1 - 2021

M3 - Poster

T2 - Cholangiocarcinoma Foundation (CCF) Annual Conference 2021

Y2 - 31 March 2021 through 2 April 2021

ER -